Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. About Intellia Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies
-
processes, structures, and functions at the finest scale to create impact on a global scale. For more information on the Mosalaganti laboratory: https://www.lsi.umich.edu/science/our-labs/mosalaganti-lab Job
-
fundamental research expertise and biomedical talent, the IGI focuses on unraveling the mechanisms underlying CRISPR-based genome editing and applying this technology to cure disease, combat climate change
-
human health. The Liu lab seeks to explore the mechanisms of CRISPR-Cas systems, and engineer their components for nucleic acid sensing, diagnostics, and other biotechnological applications. Under
-
alterations impact human lymphocyte development. By combining CRISPR-based genome engineering, induced pluripotent stem cells (iPSCs), and advanced thymus and bone marrow organoid systems, we study both
-
as neoepitopes, CRISPR screens for antigen presentation, and HLA presentation of cryptic peptides What we offer Full-time, 36-month employment contracts with full social security under MSCA conditions
-
details, please view https://www.ntu.edu.sg/medicine We are looking for a Research Fellow to support the MOE Tier 2 research project "Construct Kidney Organoids with Higher-Order Tissue Architecture
-
. The successful candidate should have extensive experience from experimental laboratory work in molecular cell biology using techniques such as cell culture, CRISPR/Cas9 based genome editing, protein expression and
-
techniques in cell culture (routine cell maintenance, transient transfections, preparation of nuclear extracts, utilization of CRISPR/Cas9) Assist with fluorescent imaging techniques, both biochemical and in
-
– signaling – proteasome – ubiquitination – multiple myeloma – mantle cell lymphoma – cancer – immunology – inflammation – infection – streptococcus – CRISPR/Cas9 – proteomics – targeted therapy Website